Evidence map›Paper›PMID 41034901›Full record

ArticleBMC medicine2025

Assessing the causal and independent impact of parity-related reproductive factors on risk of breast cancer subtypes.

Claire Prince, Laura D Howe, Eleanor Sanderson, Gemma C Sharp, Abigail Fraser, Bethan Lloyd-Lewis, Rebecca C Richmond

Abstract read
In one paragraph

Article in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Evaluation of a National Breast Cancer Screening Program in a Middle-Income Country: The Case of Kazakhstan.International journal of environmental research and public health · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Claire PrinceMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK. claire.prince@bristol.ac.uk.
Laura D HoweMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Eleanor SandersonMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Gemma C SharpMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Abigail FraserMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Bethan Lloyd-LewisSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
Rebecca C RichmondMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Funding

Academy of Medical Sciences SBF003/1170Cancer Research UK C18281/A19169Medical Research Council MR/M020894/1Wellcome Trust 108902/B/15/ZWellcome Trust 204813/Z/16/Z
6 · The paper itself

Abstract

backgroundObservational evidence proposes a protective effect of having children and an early first pregnancy on breast cancer development; however, the causality of this association remains uncertain. Here, we assess whether parity-related reproductive factors impact breast cancer risk independently of each other and other causally related or genetically correlated factors: adiposity, age at menarche, and age at menopause.

methodsWe used genetic data from UK Biobank for reproductive factors and adiposity, and the Breast Cancer Association Consortium for risk of overall, estrogen receptor (ER) positive and negative breast cancer, and breast cancer subtypes. We applied univariable and multivariable Mendelian randomization (MR) to estimate genetically predicted direct effects of ever parous status, ages at first birth and last birth, and number of births on breast cancer risk.

resultsWe found limited evidence for a genetically predicted protective effect of an earlier age at first birth on breast cancer risk. While the univariable analysis revealed later age at first birth decreased ER-negative breast cancer risk (odds ratio (OR): 0.76; 95% confidence interval: 0.61, 0.95 per standard deviation (SD) increase in age at first birth), this effect attenuated with separate adjustment for age at menarche (potential confounder) (OR: 0.83; 0.62, 1.06) and age at menopause (genetically correlated factor) (OR: 0.80; 0.66, 1.01). Furthermore, we found evidence that a later age at first birth decreased HER2-enriched breast cancer risk but only after adjusting for number of births (potential mediator) (OR: 0.28; 0.11, 0.57 per SD increase in age at first birth). In the multivariable analysis, we found little evidence for genetically predicted effects of ever-parous status, age at last birth, or number of births on breast cancer risk; however, analyses of ever-parous status and age at last birth were limited by weak instruments.

conclusionsThis study found minimal evidence of a genetically predicted protective effect of earlier age at first birth on breast cancer risk, while identifying some evidence for a genetically predicted adverse effect on ER-negative breast cancer risk. However, weak instruments limited the multivariable analysis of ever parous status and age at last birth, which may be improved with larger sample sizes.

Indexed as

Breast NeoplasmsParityAdultAgedAge FactorsFemaleHumansMenarcheMendelian Randomization AnalysisMiddle AgedPregnancyRisk FactorsUnited KingdomBCACBreast cancer riskMendelian randomizationReproductive factorsUK Biobank

Identifiers

PMID41034901
PMCPMC12487161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.